SCHEMBL694207

SCHEMBL694207

COc1ccc(-c2cc3c[c]ccc3[nH]2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.47
FGFR3 P22607 1/20 0.42
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
MAPT P10636 4/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
TDO2 P48775 1/20 0.40
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
CYP2A6 P11509 2/20 0.38
KIT P10721 2/20 0.38
CLK1 P49759 1/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CD O00329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694550 0.83 HPGDS (0.44) MAPTKDM4ENPC1RAB9ACASP3
SCHEMBL695292 0.82 RAB9A (0.61) LOXL2FGFR3PDGFRBPDGFRAMAPT
SCHEMBL694481 0.81 IDO1 (0.42) MAPTKDM4ENPC1RAB9ACASP3
SCHEMBL699731 0.76 PIK3CA (0.38) KITPIK3CAPIK3CDPIK3CBPI4KA
SCHEMBL21812390 0.74 LOXL2 (0.54) LOXL2FGFR3PDGFRBPDGFRAMAPT
SCHEMBL693900 0.72 CYP19A1 (0.44) MAPTKDM4ENPC1RAB9ACASP3
SCHEMBL694356 0.71 CYP19A1 (0.68) MAPTKDM4ENPC1RAB9ACYP2A6
SCHEMBL31308704 0.71 FGFR3 (0.48) LOXL2FGFR3PDGFRBPDGFRAMAPT
SCHEMBL695252 0.71 AR (0.44) MAPTKDM4ENPC1RAB9ACASP3
SCHEMBL21812340 0.71 LOXL2 (0.57) LOXL2FGFR3PDGFRBPDGFRAHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed